By Ana S. Iltis, Grace Koster, Emily Reeves & Kirstin R. W. Matthews

Abstract

Recent advances in methods to culture…

Abstract

Scholars began reporting about this marketplace in the mid-2000s; however, there is no sign of it dissipating…

Vaccination policies are a cornerstone of public health, but anti-vaccine activists have been adamantly pushing for legislation that would weaken and dismantle the public health infrastructure, the authors write. In this issue brief, they examine vaccine policy challenges leading up to and during the COVID-19 pandemic, as well as the future of vaccine legislation in Texas and the United States.

The authors identify key themes that emerged from anti-vaccine testimonies during the 2021 Texas legislative session and consider the implications of these discussions as the next legislative session draws near.

Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).

The intense marketing of unproven stem cell interventions has become an international health concern. The authors offer resources and suggestions for physicians seeking to effectively counsel patients and respond to their questions about various stem cell therapies.

The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.

"The COVID-19 effect is likely to reduce the demand for public transport in favor of lower density alternatives," write the authors. Their study considers links between commuters' demographic factors and incidence of disease transmission, as well as the environmental implications of decreased ridership on public transport.

This journal article explores why the public and stakeholders should help develop guidelines and policies governing scientific practices for controversial biomedical research issues, such as genetically editing human embryos.